Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 1186 AL 1200

AMYPAD Diagnostic and Patient Management Study: Rationale and design

Frisoni GB, Barkhof F, Altomare D, Berkhof J, Boccardi M, Canzoneri E, Collij L, Drzezga A, Farrar G, Garibotto V, Gismondi R, Gispert JD, Jessen F, Kivipelto M, Lopes Alves I, Molinuevo JL, Nordberg A, Payoux P, Ritchie C, Savicheva I, Scheltens P, Schmidt ME, Schott JM, Stephens A, van Berckel B, Vellas B, Walker Z, Raffa N.

Alzheimers Dement. 2019 Mar;15(3):388-399. doi: 10.1016/j.jalz.2018.09.003. Epub 2018 Oct 16.

Validation of the Thai version of the short Boston Naming Test (T-BNT) in patients with Alzheimer's dementia and mild cognitive impairment: clinical and biomarker correlates

Aniwattanapong D, Tangwongchai S, Supasitthumrong T, Hemrunroj S, Tunvirachaisakul C, Tawankanjanachot I, Chuchuen P, Snabboon T, Carvalho AF, Maes M.

Aging Ment Health. 2019 Jul;23(7):840-850. doi: 10.1080/13607863.2018.1501668. Epub 2018 Oct 23.

Resting-State Functional Connectivity in Subjective Cognitive Impairment: Impairment prior to Alzheimer Disease

Caspers S.

Radiology. 2019 Jan;290(1):177-178. doi: 10.1148/radiol.2018182207. Epub 2018 Oct 23.

Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer's Disease and Melatonin

Spinedi E, Cardinali DP.

Neuroendocrinology. 2019;108(4):354-364. doi: 10.1159/000494889. Epub 2018 Oct 28.

Quanti-qualitative components of the semantic verbal fluency test in cognitively healthy controls, mild cognitive impairment, and dementia subtypes

Wajman JR, Cecchini MA, Bertolucci PHF, Mansur LL.

Appl Neuropsychol Adult. 2019 Nov-Dec;26(6):533-542. doi: 10.1080/23279095.2018.1465426. Epub 2018 Oct 30.

Subjective cognitive decline: preclinical manifestation of Alzheimer's disease

Lin Y, Shan PY, Jiang WJ, Sheng C, Ma L.

Neurol Sci. 2019 Jan;40(1):41-49. doi: 10.1007/s10072-018-3620-y. Epub 2018 Nov 5.

Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease

Chen Z, Mengel D, Keshavan A, Rissman RA, Billinton A, Perkinton M, Percival-Alwyn J, Schultz A, Properzi M, Johnson K, Selkoe DJ, Sperling RA, Patel P, Zetterberg H, Galasko D, Schott JM, Walsh DM.

Alzheimers Dement. 2019 Mar;15(3):487-496. doi: 10.1016/j.jalz.2018.09.010. Epub 2018 Nov 9.

Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies

Boyle PA, Yu L, Leurgans SE, Wilson RS, Brookmeyer R, Schneider JA, Bennett DA.

Ann Neurol. 2019 Jan;85(1):114-124. doi: 10.1002/ana.25380. Epub 2018 Dec 19.

Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's Disease (AD) in the elderly?

Pinto TCC, Machado L, Bulgacov TM, Rodrigues-Júnior AL, Costa MLG, Ximenes RCC, Sougey EB.

Int Psychogeriatr. 2019 Apr;31(4):491-504. doi: 10.1017/S1041610218001370. Epub 2018 Nov 14.

Targeting hippocampal adult neurogenesis using transcription factors to reduce Alzheimer's disease-associated memory impairments

Dard RF, Dahan L, Rampon C.

Hippocampus. 2019 Jul;29(7):579-586. doi: 10.1002/hipo.23052. Epub 2018 Nov 25.

Neuroprotective effects of exercise in rodent models of memory deficit and Alzheimer's

Jahangiri Z, Gholamnezhad Z, Hosseini M.

Metab Brain Dis. 2019 Feb;34(1):21-37. doi: 10.1007/s11011-018-0343-y. Epub 2018 Nov 15.

Impaired brain plasticity as a potential therapeutic target for treatment and prevention of dementia

Rajji TK.

Expert Opin Ther Targets. 2019 Jan;23(1):21-28. doi: 10.1080/14728222.2019.1550074. Epub 2018 Nov 30.

Apolipoprotein E and affective symptoms in mild cognitive impairment and Alzheimer's disease dementia: A systematic review and meta-analysis

Banning LCP, Ramakers IHGB, Deckers K, Verhey FRJ, Aalten P.

Neurosci Biobehav Rev. 2019 Jan;96:302-315. doi: 10.1016/j.neubiorev.2018.11.020. Epub 2018 Dec 1.

Medical decision-making in progressive supranuclear palsy: A comparison to other neurodegenerative disorders

Gerstenecker A, Grimsley L, Otruba B, Cowden L, Marson DC, Gerstenecker KT, Martin RC, Roberson ED.

Parkinsonism Relat Disord. 2019 Apr;61:77-81. doi: 10.1016/j.parkreldis.2018.11.022. Epub 2018 Nov 26.

Unsupervised excitation: GABAergic dysfunctions in Alzheimer's disease

Ambrad Giovannetti E, Fuhrmann M.

Brain Res. 2019 Mar 15;1707:216-226. doi: 10.1016/j.brainres.2018.11.042. Epub 2018 Nov 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias